Search Results - "Fröss-Baron, Katarzyna" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

by Garske-Román, Ulrike, Sandström, Mattias, Fröss Baron, Katarzyna, Lundin, Lars, Hellman, Per, Welin, Staffan, Johansson, Silvia, Khan, Tanweera, Lundqvist, Hans, Eriksson, Barbro, Sundin, Anders, Granberg, Dan
Published in European journal of nuclear medicine and molecular imaging (2018)

Get full text

Journal Article

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

by Papantoniou, Dimitrios, Fröss-Baron, Katarzyna, Garske-Román, Ulrike, Sundin, Anders, Thiis-Evensen, Espen, Grönberg, Malin, Welin, Staffan, Tiensuu Janson, Eva
Published in Journal of neuroendocrinology (13.03.2024)

Get full text

Journal Article

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

by Sandström, Mattias, Freedman, Nanette, Fröss-Baron, Katarzyna, Kahn, Tanweera, Sundin, Anders
Published in EJNMMI physics (09.12.2020)

Get full text

Journal Article

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT

by Jahn, Ulrika, Ilan, Ezgi, Velikyan, Irina, Fröss-Baron, Katarzyna, Lubberink, Mark, Sundin, Anders
Published in EJNMMI research (25.11.2021)

Get full text

Journal Article

Tumor Contrast-Enhancement for Monitoring of PRRT 177Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Tumor Contrast-Enhancement for Monitoring of PRRT 177Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

by Pettersson, Olof, Fröss-Baron, Katarzyna, Crona, Joakim, Sundin, Anders
Published in Frontiers in oncology (21.02.2020)

Get full text

Journal Article

Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE

Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE

by Pettersson, Olof Joakim, Fröss-Baron, Katarzyna, Crona, Joakim, Sundin, Anders
Published in Endocrine Connections (22.04.2021)

Get full text

Journal Article

Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

by Pettersson, Olof, Fröss-Baron, Katarzyna, Crona, Joakim, Sundin, Anders
Published in Frontiers in oncology (21.02.2020)

Get full text

Journal Article

In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy

In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy

by Lubberink, Mark, Wilking, Helena, Öst, Amalia, Ilan, Ezgi, Sandström, Mattias, Andersson, Camilla, Fröss-Baron, Katarzyna, Velikyan, Irina, Sundin, Anders
Published in The Journal of nuclear medicine (1978) (01.09.2020)

Get full text

Journal Article

In Vivo Instability of 177 Lu-DOTATATE During Peptide Receptor Radionuclide Therapy

In Vivo Instability of 177 Lu-DOTATATE During Peptide Receptor Radionuclide Therapy

by Lubberink, Mark, Wilking, Helena, Öst, Amalia, Ilan, Ezgi, Sandström, Mattias, Andersson, Camilla, Fröss-Baron, Katarzyna, Velikyan, Irina, Sundin, Anders
Published in Journal of Nuclear Medicine (01.09.2020)

Get full text

Journal Article

Tumor Contrast-Enhancement for Monitoring of PRRT 177 Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Tumor Contrast-Enhancement for Monitoring of PRRT 177 Lu-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

by Pettersson, Olof, Fröss-Baron, Katarzyna, Crona, Joakim, Sundin, Anders
Published in Frontiers in oncology (2020)

Get full text

Journal Article

Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving 177 Lu-DOTATATE therapy

Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving 177 Lu-DOTATATE therapy

by Sandström, Mattias, Fröss-Baron, Katarzyna, Khan, Tanweera Shaheena, Granberg, Dan, Sundin, Anders, Lubberink, Mark
Published in European journal of nuclear medicine and molecular imaging (2018)

Get full text

Journal Article

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by Ga-68-DOTATOC PET/CT

by Jahn, Ulrika, Ilan, Ezgi, Velikyan, Irina, Fröss-Baron, Katarzyna, Lubberink, Mark, Sundin, Anders
Published in EJNMMI research (2021)

Get full text

Journal Article

In-vivo stability of 177 Lu-DOTATATE during peptide receptor radionuclide therapy

In-vivo stability of 177 Lu-DOTATATE during peptide receptor radionuclide therapy

by Wilking, H., Ilan, Ezgi, Sandström, Mattias, Andersson, C., Öst, A., Velikyan, Irina, Fröss-Baron, Katarzyna, Sundin, Anders, Lubberink, Mark
Published in European journal of nuclear medicine and molecular imaging (2018)

Get full text

Journal Article

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors

177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors

by Jahn, Ulrika, Ilan, Ezgi, Sandström, Mattias, Garske-Román, Ulrike, Velikyan, Irina, Fröss-Baron, Katarzyna, Lubberink, Mark, Sundin, Anders
Published in European journal of nuclear medicine and molecular imaging (2018)

Get full text

Journal Article

Comparison of Ga-68-DOTATATE and Lu-177-DOTATATE kinetics in neuroendocrine tumors

Comparison of Ga-68-DOTATATE and Lu-177-DOTATATE kinetics in neuroendocrine tumors

by Ilan, Ezgi, Lubberink, Mark, Sandström, Mattias, Jahn, Ulrika, Velikyan, Irina, Andersson, Camilla, Fröss-Baron, Katarzyna, Sundin, Anders
Published in European journal of nuclear medicine and molecular imaging (2018)

Get full text

Journal Article

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

by Fröss-Baron, Katarzyna, Garske-Roman, Ulrike, Welin, Staffan, Granberg, Dan, Eriksson, Barbro, Khan, Tanweera, Sandström, Mattias, Sundin, Anders
Published in Neuroendocrinology (2021)

Get full text

Journal Article

Kidney dosimetry in 777 patients during 177 Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Kidney dosimetry in 777 patients during 177 Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

by Sandström, Mattias, Freedman, Nanette, Fröss-Baron, Katarzyna, Kahn, Tanweera, Sundin, Anders
Published in EJNMMI physics (09.12.2020)

Get full text

Journal Article

Gender-related differences in absorbed dose to risk organs in patients receiving Lu-177-Octreotate therapy

Gender-related differences in absorbed dose to risk organs in patients receiving Lu-177-Octreotate therapy

by Sandström, Mattias, Ilan, Ezgi, Fröss-Baron, Katarzyna, Garske, Ulrike, Granberg, Dan, Eriksson, Barbro, Sundin, Anders, Lubberink, Mark
Published in European journal of nuclear medicine and molecular imaging (2017)

Get full text

Journal Article

Prospective observational study of 177 Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Prospective observational study of 177 Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

by Garske-Román, Ulrike, Sandström, Mattias, Fröss Baron, Katarzyna, Lundin, Lars, Hellman, Per, Welin, Staffan, Johansson, Silvia, Khan, Tanweera, Lundqvist, Hans, Eriksson, Barbro, Sundin, Anders, Granberg, Dan
Published in European journal of nuclear medicine and molecular imaging (01.06.2018)

Get full text

Journal Article

Favourable outcome after 177Lu-DOTA-octreotate therapy of patients with neuroendocrine of the rectum -an update

Favourable outcome after 177Lu-DOTA-octreotate therapy of patients with neuroendocrine of the rectum -an update

by Garske-Roman, Ulrike E., Sandström, Mattias, Johansson, Silvia, Fröss-Baron, Katarzyna, Sundin, Anders, Eriksson, Barbro, Granberg, Dan
Published in European journal of nuclear medicine and molecular imaging (2014)

Get full text

Journal Article